Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page
- Check4 days agoChange DetectedDeleted the Study Protocol and Statistical Analysis Plan PDF along with several boilerplate/footer items from the study page.SummaryDifference20%

- Check11 days agoChange DetectedThe update appears to be a site-wide template revision (Revision: v3.4.2) with removal of certain footer sponsor links; these changes do not modify the trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check19 days agoChange DetectedThe page revision updates from v3.4.0 to v3.4.1, with no substantive changes to study details, eligibility criteria, outcomes, or timelines.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now shows Last Update Posted instead of Last Update Posted (Estimated), clarifying the update timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a dedicated Locations section listing Tampa, Florida (H. Lee Moffitt Cancer Center and Research Institute) as the study site; removed the prior Florida Locations entry.SummaryDifference0.2%

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.